Peyressatre et al. exhibited a cyclin-dependent kinase 5 (CDK5) kinase activity biosensor for the diagnosis of neurodegenerative pathologies, including glioblastoma and neuroblastoma [93]. Here, CDK5 is linked to glioblastoma.